Ganirelix-Get quote

Description

Ganirelix is a competitive and selective gonadotropin releasing hormone (GnRH) antagonist. Ganirelix prevents endogenous GnRH from inducing luteinising hormone (LH) and follicle stimulating hormone relea[1].—Metabolism-protein/nucleotide metabolism–C80H113ClN18O13—-[1]Gillies PS, et al. Ganirelix. Drugs. 2000 Jan;59(1):107-11; discussion 112-3.|[2]Russo A, et al. Effects of the gonadotropin-releasing hormone antagonist ganirelix on normal micturition and prostaglandin E(2)-induced detrusor overactivity in conscious female rats. Eur Urol. 2011 May;59(5):868-74.–124904-93-4–1570.32—-C([C@@H](NC([C@@H](NC([C@H](NC([C@H](CC1=CC=C(O)C=C1)NC([C@@H](NC([C@H](NC([C@@H](CC2=CC=C(Cl)C=C2)NC([C@@H](CC3=CC4=C(C=C3)C=CC=C4)NC(C)=O)=O)=O)CC=5C=CC=NC5)=O)CO)=O)=O)CCCCN=C(NCC)NCC)=O)CC(C)C)=O)CCCCN=C(NCC)NCC)(=O)N6[C@H](C(N[C@@H](C(N)=O)C)=O)CCC6–Metabolic Disease–10 mM in DMSO–GnRH Receptor—-GPCR/G Protein–Peptides